Free Trial

Roche ROSW (Aa2/AA): New Issue 6yr & 20yr Benchmarks

CREDIT SUPPLY
  • 5yr IPT +65.
  • 20yr IPT +110/115.
  • WE see FV at +35 and +80 respectively.
  • The 6yr should come close to the secondary curve.
  • For the 20yr Eli Lilly (A1/A+) provides a useful comp for longer dated Pharma. See graph.

49 words

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.
  • 5yr IPT +65.
  • 20yr IPT +110/115.
  • WE see FV at +35 and +80 respectively.
  • The 6yr should come close to the secondary curve.
  • For the 20yr Eli Lilly (A1/A+) provides a useful comp for longer dated Pharma. See graph.